Shamkant Mulgaonkar

Statistics

Publications

Citations

2.7K

H-Index

Active since

1996

Affiliations

Saint Barnabas Medical Center(Current)

Hospital do Rim e Hipertensão

University of California, San Francisco

Novartis (Switzerland)

Medical University of South Carolina

Shamkant Mulgaonkar is an author at Saint Barnabas Medical Center specializing in kidney transplantation, medicine, and immunosuppression in kidney transplantation.

Publications per year

1996–2019

Publications

Alemtuzumab Induction in Renal Transplantation

Michael J. Hanaway, E. Steve Woodle, Shamkant Mulgaonkar et al. · New England Journal of Medicine · 2011 · 380 citations

Life Sciences, Immunology, Nephrology +14

Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation

Julio Pascual, Stefan P. Berger, Oliver Witzke et al. · Journal of the American Society of Nephrology · 2018 · 244 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Everolimus versus Mycophenolate Mofetil in the Prevention of Rejection in De Novo Renal Transplant Recipients: A 3-Year Randomized, Multicenter, Phase III Study

Marc I. Lorber, Shamkant Mulgaonkar, Khalid M.H. Butt et al. · Transplantation · 2005 · 232 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

FTY720, A Novel Immunomodulator: Efficacy and Safety Results from the First Phase 2A Study in de novo Renal Transplantation

Hélio Tedesco‐Silva, Georges Mourad, Barry D. Kahan et al. · Transplantation · 2004 · 216 citations

Medicine, Immunology, Pharmacology +17

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial

Matthew R. Weir, Shamkant Mulgaonkar, Laurence Chan et al. · Kidney International · 2010 · 183 citations

Medicine, Nephrology, Pharmacotherapy +14

1–5 of 28